I recently sat down with a patient named Martha, a vibrant 68-year-old grandmother who told me she felt like a shadow of her former self.
“I’m active, I eat well, and I volunteer,” she said, “but my body feels like a house where the electricity is flickering out. My previous doctor told me I had to stop my hormones at 65 because of ‘the rules.’ Now, my joints ache, I can’t sleep, and I just feel … brittle.”
What Martha didn’t know was that her doctor was following an outdated rule that medical experts have since abandoned.
The Rule That Wasn’t Really a Rule
For more than 20 years, the “65-and-out” rule for hormone replacement therapy (HRT) dominated U.S. medicine. The practice emerged from a cautious interpretation of the 2002 Women’s Health Initiative (WHI) study, which initially highlighted risks that seemed to outweigh the benefits for older women. Doctors responded by reflexively pulling the plug on hormone support at age 65, treating it as a hard cutoff.
However, major medical organizations have now moved away from arbitrary stopping points. Both The Menopause Society and the American College of Obstetricians and Gynecologists now agree: If a woman is healthy and her quality of life is thriving on HRT, she can often continue indefinitely with annual check-ins.
The shift reflects a more nuanced understanding of the original WHI data and subsequent research. Today, the conversation for a woman older than 65 is no longer a “no”—it is a “how.” Simply put, the key isn’t age—it’s timing and individual health status.
Why Timing Matters More Than Age
The most significant factor in HRT safety isn’t when you stop, but when you start. Researchers call this the “timing hypothesis.”
Think of your arteries like the plumbing in an old house. If a woman starts HRT right at the onset of menopause, typically in their late 40s or early 50s, estrogen acts like a maintenance crew, keeping the pipes clear. The protective effects of estrogen on blood vessels are well established; it helps keep vessels open, optimizes the balance of HDL/LDL cholesterol, prevents oxidative stress that turns cholesterol into “hard” plaque, and helps keep the arterial wall from thickening and becoming stiff.
However, if she waits until 20 years after menopause to start for the very first time, her blood vessels may have already developed hardened plaques or atherosclerosis. Introducing systemic estrogen at that late stage can sometimes destabilize the plaque, which is why we have to be incredibly cautious and discerning with “late starters.” A vascular system that is already inflamed requires a completely different approach than a healthy one.
Beyond the Idea of the Body as a Machine
To get this right, we have to move past reactive “sickness care” and toward proactive “health care.” In my practice, I use what I call the ACES Model—anatomy, chemistry, energy, and soul. It’s a way to ensure that we aren’t just managing symptoms but actually cultivating vitality.
In the ACES framework, we look at the body as an integrated whole:
A and C—Anatomy and Chemistry: These are your physical foundations. We know that HRT is a primary defense against osteoporosis. In fact, estrogen-based therapy reduces the risk of hip and vertebral fractures by more than 30 percent based on data from the WHI study and other studies. For localized issues such as genitourinary syndrome of menopause, localized vaginal estrogen is a godsend; it restores tissue integrity without significant chemical absorption into the rest of the system.
E and S—Energy and Soul: This is where modern medicine often misses the mark. In traditional healing and Chinese medicine, health is defined by the smooth flow of vital energy (qi). Estrogen is a massive player here as well; it influences our circadian rhythms and the stability of our nervous system. HRT remains the most effective treatment for vasomotor symptoms. When we stabilize these “circuits,” we provide the resilience a woman needs to maintain her sense of purpose and identity—what I call the soul of her health.
For my patients older than 65, I almost always prefer transdermal delivery—patches, gels, or sprays. Because these bypass the liver, they don’t trigger the same clotting factors as the old-school oral pills, drastically reducing the risk of stroke or venous thromboembolism, similar to the recommendations of the British Menopause Society guidelines.
A Roadmap Grounded in Wisdom
The current medical system is great at managing a crisis, yet often poor at fostering long-term vigor. Modern women are pushing back. They don’t want to be treated as a collection of lab values—they want autonomy.
In order to achieve this and carry out HRT safely, health providers must identify the “red flags,” which include previous “circuit failures”—such as heart attacks or strokes—or a personal history of estrogen-sensitive cancers. For those women whose circuits are stable and whose “anatomy” needs support, HRT is a bridge back to themselves.
Continue the Journey With Me
We are just scratching the surface of what it means to age with power. This is the fourth in a series of articles where we peel back the layers of midlife health.
In the coming weeks, I’ll be sharing:
The Energetic Lens: A deep dive into how Chinese medicine and homeopathy evaluate and treat postmenopausal issues.
The Hormone Nuance: A candid look at the differences between bioidentical hormones and pharmaceutical treatments, so you can choose the “chemistry” that fits your unique body.
I invite you to continue this journey with me. We are moving toward a future where we stop treating women as “bodies to fix” and start treating them as “lives to understand.” It’s time to restore the individual’s wholeness.
Lidan Du-Skabrin, who has a doctorate in nutrition, also contributed to this article.
Views expressed in this article are the opinions of the author and do not necessarily reflect the views of The Epoch Times. Epoch Health welcomes professional discussion and friendly debate. To submit an opinion piece, please follow these guidelines and submit through our form here.